LBPWQ 4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM)
- 0.000100
- 0.0000000.00%
4D PHARMA PLC C/WTS 22/03/2026 (TO PUR COM) News
Microbiomes Market Size to Grow at a CAGR of 21.95% by 2027, Evolving Opportunities With 4D Pharma Plc, AOBiome LLC, Among Others - Technavio
Human Microbiome Market Report (2022 to 2030) – Obiome, 4D Pharma, Vedanta Biosciences, Second Genome, Ferring Pharmaceuticals
Pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, "Human Microbiome Market by Product (Probiotics, Prebiotics, Symbiotics, Medical Food, Drugs and Others), by Disease (Obesity,
4D Pharma to Hold Vote on Financial Rescue Package
By Kyle Morris 4D pharma PLC said Friday that it will hold a meeting for shareholders on Jan. 16 to vote on a financial package offered by U.S.-based specialist healthcare investor Armistice which co
Worldwide Human Microbiome Industry to 2028 - Players Include Seres Therapeutics, 4D Pharma, OptiBiotix Health and Synlogic - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Regional Outlook and
Global Human Microbiome Market Analysis to 2031 - Players Include Synthetic Biologics, YSOPIA Bioscience, 4D Pharma and DuPont De Nemours Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Human Microbiome Market Analysis 2021-2031" report has been added to ResearchAndMarkets.com's offering. The global human microbiome market is anticipated to grow w
Global Microbiome Therapeutics Market Report 2022: Featuring 4D Pharma, Enterome, Finch Therapeutics, Vedanta Bioscience & More
DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "Global Microbiome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (FMT v/s Microbiome Drugs), By Application
4D Pharma (LON:DDDD) Trading 5% Higher
4D pharma plc (LON:DDDD – Get Rating)'s share price traded up 5% on Tuesday . The stock traded as high as GBX 16.86 ($0.20) and last traded at GBX 16.66 ($0.20). 912,370 shares were traded during mi
4D Pharma Remains Suspended From Trading on London's AIM
05:40 AM EDT, 09/29/2022 (MT Newswires) -- 4D pharma (DDDD.L) on Thursday said it will continue to be suspended from trading on the London stock exchange's AIM segment as it warned it will not release
4D Pharma (LON:DDDD) Trading Up 5%
4D pharma plc (LON:DDDD – Get Rating)'s share price was up 5% during trading on Tuesday . The stock traded as high as GBX 16.86 ($0.20) and last traded at GBX 16.66 ($0.20). Approximately 912,370 sha
Repeat & Correct: 4D Pharma Administrators Uncertain Whether Rescuing Company Is Achievable
The joint administrators of 4D pharma PLC said that they weren't sure whether the company could be rescued given the uncertainty of the continuing sale process, but that they will do everything possib
4D Pharma Is Uncertain Whether Rescuing the Company Is Achievable
By Anthony O. Goriainoff 4D pharma PLC said Thursday that given the uncertainty of the continuing sale of business process, it was currently uncertain whether rescuing the company was achievable. Th
4D pharma (LON:DDDD) Shares Up 5%
Shares of 4D pharma plc (LON:DDDD – Get Rating) shot up 5% on Monday . The company traded as high as GBX 16.86 ($0.21) and last traded at GBX 16.66 ($0.20). 912,370 shares were traded during mid-day
Delisting of Securities of Alberton Acquisition Corporation; Zosano Pharma Corporation; Electric Last Mile Solutions, Inc.; 4D pharma plc; and Enjoy Technology, Inc. from The Nasdaq Stock Market
NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares, warrant, unit, and rights of Alberton Acquisition Corporation. Alberton Acquisition Corporation's securities were suspended o
Analysis
Price Target
No Data
